Long-term atropine use to treat myopia associated with increased risk of ocular complication in schoolchildren in Taiwan

While teprotumumab was found to be effective in reducing clinical activity score and proptosis in geriatric thyroid eye disease patients with short-term follow-up, recurrence was common and  one-third of subjects discontinued because of adverse effects. Photo:  Bobby Saenz, OD. Click image to enlarge. Teprotumumab has had a major impact on thyroid eye disease (TED) since its